Alleviare Life sciences Private Limited
Named Patient Program
Schedule a free consultation with our team and let’s make things happen!
Let us help you
Named-patient access programme (NPP)
Name Patient Program, often referred to as NPP, are initiatives established to provide controlled and regulated access to investigational or unapproved medical treatments for patients who have exhausted other treatment options and meet specific eligibility criteria.
The primary purpose of Name patient program is to offer access to potentially life-saving or disease-altering therapies when the prescribed Medicines not approved in the patient’s country but are approved and available in at other countries.
These programs go by various names, including Compassionate Use, Manage Access Program, and Individual Patient Request, among others. The terminology may vary depending on the region and its regulatory framework.
Alleviare Life Sciences assists eligible patients to access specific medicines. To initiate a request, the treating physician or the patient in need of a particular medicinal product must submit the request to Alleviare.
These may be medicines that are:
- Authorised but not yet available to be prescribed in the patient’s country.
- Authorised and available in one country but not authorised and available in the patient’s country.
- Discontinued in the patient’s country but not in another country.
- In shortage in the patient’s country but not in another country.
Our Services
Our Skills
Specialty Drugs
Our specialty pharmacy service provides support for the following medications. *This list is not all-inclusive. Please contact our team for details concerning other available products.
Oncology | Inflammatory Conditions | Hepatitis | Multiple Sclerosis and Neurology | Human Immunodeficiency Virus (HIV) | Pulmonary Arterial Hypertension | Hematology | Hemophilia | Infertility | Transplant | Growth Hormone Deficiency | and more
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
Named Patient Basis Access
Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).
